4/A: Vera Therapeutics CEO Sells Shares
Insider Transaction (Form 4/A)
Marshall Fordyce, PRESIDENT AND CEO and a Director of Vera Therapeutics, Inc., sold 18,500 shares of common stock on June 23, 2026.
Summary
- Option exercise/conversion: acquired 18,500 Class A Common Stock at $2.90 ($53,591) on June 23, 2026; holds 253,744 after (Direct).
- Open-market sale: disposed of 18,412 Class A Common Stock at $37.93 ($698,387) on June 23, 2026; holds 235,332 after (Direct).
- Open-market sale: disposed of 88 Class A Common Stock at $38.43 ($3,382) on June 23, 2026; holds 235,244 after (Direct).
- Option exercise/conversion: disposed of 18,500 Stock Option (Right to Buy) on June 23, 2026; holds 572,051 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $701,769 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Marshall Fordyce — Director, Officer (PRESIDENT AND CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-23 | Option exercise/conversion | Class A Common Stock | 18,500 | $3 | $53.6K | 253,744 |
| 2026-06-23 | Open-market sale | Class A Common Stock | 18,412 | $38 | $698.4K | 235,332 |
| 2026-06-23 | Open-market sale | Class A Common Stock | 88 | $38 | $3.4K | 235,244 |
| 2026-06-23 | Option exercise/conversion | Stock Option (Right to Buy) | 18,500 | — | — | 572,051 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-23 | Option exercise/conversion (18,500 shares) |
| 2026-06-23 | Open-market sale (18,412 shares) |
| 2026-06-23 | Open-market sale (88 shares) |
| 2026-06-23 | Option exercise/conversion (18,500 shares) |
Keywords
insider transaction, Form 4/A, VERA, Vera Therapeutics, Inc., bearish, Marshall Fordyce
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.